Literature DB >> 12490317

L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma.

Mina Fogel1, Sabine Mechtersheimer, Monica Huszar, Asya Smirnov, Adel Abu-Dahi, Wolfgang Tilgen, Jörg Reichrath, Thomas Georg, Peter Altevogt, Paul Gutwein.   

Abstract

The L1 adhesion molecule (CD171) plays an important role in axon guidance and cell migration in the nervous system. In the human, L1 is expressed on tumors derived from neurocrest and on certain carcinomas. We have analyzed immunohistochemically L1 expression on paraffin embedded specimens of acquired melanocytic nevi, primary cutaneous melanomas, and cutaneous and lymph node metastases of malignant melanomas. We found an increase in L1 immunoreactivity in malignant melanomas and metastases of malignant melanomas as compared to acquired melanocytic nevi that was statistically significant (P<0.05). Additionally, a correlation of L1 immunoreactivity with histological data of prognostic value such as Clark level and the expression of alphav-integrins was found. We detected soluble L1 in the conditioned medium of cultivated melanoma cells but only in 1/40 serum samples from a panel of melanoma patients representing various stages of disease. Our findings suggest that the presence of L1 might contribute to tumor progression by promoting cell adhesion and migration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12490317     DOI: 10.1016/s0304-3835(02)00513-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  26 in total

1.  Expression of L1 protein correlates with cluster of differentiation 24 and integrin β1 expression in gastrointestinal stromal tumors.

Authors:  Yue DU; Haihong Zhang; Zhongmin Jiang; Guowei Huang; Wenli Lu; Hesheng Wang
Journal:  Oncol Lett       Date:  2015-04-02       Impact factor: 2.967

2.  Acinar cell carcinomas of the pancreas: a molecular analysis in a series of 57 cases.

Authors:  Frank Bergmann; Sebastian Aulmann; Bence Sipos; Matthias Kloor; Anja von Heydebreck; Johannes Schweipert; Andreas Harjung; Philipp Mayer; Werner Hartwig; Gerhard Moldenhauer; David Capper; Gerhard Dyckhoff; Kolja Freier; Esther Herpel; Anja Schleider; Peter Schirmacher; Gunhild Mechtersheimer; Günter Klöppel; Hendrik Bläker
Journal:  Virchows Arch       Date:  2014-10-09       Impact factor: 4.064

Review 3.  "CRASH"ing with the worm: insights into L1CAM functions and mechanisms.

Authors:  Lihsia Chen; Shan Zhou
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

4.  L1CAM from human melanoma carries a novel type of N-glycan with Galβ1-4Galβ1- motif. Involvement of N-linked glycans in migratory and invasive behaviour of melanoma cells.

Authors:  Dorota Hoja-Łukowicz; Paweł Link-Lenczowski; Andrea Carpentieri; Angela Amoresano; Ewa Pocheć; Konstantin A Artemenko; Jonas Bergquist; Anna Lityńska
Journal:  Glycoconj J       Date:  2012-04-29       Impact factor: 2.916

5.  Inside-out regulation of L1 conformation, integrin binding, proteolysis, and concomitant cell migration.

Authors:  Maxine M Chen; Chia-Yao Lee; Hyuma A Leland; Grace Y Lin; Anthony M Montgomery; Steve Silletti
Journal:  Mol Biol Cell       Date:  2010-03-24       Impact factor: 4.138

6.  L1CAM is involved in lymph node metastasis via ERK1/2 signaling in colorectal cancer.

Authors:  Qing-Xia Fang; Xiao-Chun Zheng; Hua-Jun Zhao
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

7.  Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration.

Authors:  Yasmin Issa; Daniel Nummer; Tobias Seibel; Susanne Sebens Müerköster; Moritz Koch; Friedrich-Hubertus Schmitz-Winnenthal; Luis Galindo; Juergen Weitz; Philipp Beckhove; Peter Altevogt
Journal:  J Mol Med (Berl)       Date:  2008-10-18       Impact factor: 4.599

8.  Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation.

Authors:  Hannah J Anderson; Deni S Galileo
Journal:  Cell Oncol (Dordr)       Date:  2016-02-16       Impact factor: 6.730

Review 9.  Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy.

Authors:  Nikolas K Haass; Keiran S M Smalley
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

10.  Stimulation of glioma cell motility by expression, proteolysis, and release of the L1 neural cell recognition molecule.

Authors:  Muhua Yang; Shalini Adla; Murali K Temburni; Vivek P Patel; Errin L Lagow; Owen A Brady; Jing Tian; Magdy I Boulos; Deni S Galileo
Journal:  Cancer Cell Int       Date:  2009-10-29       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.